Bioavailability and Vascular Effects of Apple Polyphenols
NCT ID: NCT01097226
Last Updated: 2013-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2010-04-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of an Apple Polyphenol Extract on Brachial Artery Flow-mediated Vasodilatory Function
NCT01690676
A Study Examining Effects of Apples/ Apple Products on Heart Disease Risk
NCT01585519
The Effects of Apple Derived Flavanols on Cardiovascular Disease Risk (FLAVASCULAR Study)
NCT02013856
The Effects of a Polyphenol-enriched Fruit Drink on Metabolic Health
NCT01706653
Effect of Polyphenol Extract on Cardiovascular Health Markers: a 4 Way Randomised Crossover Study
NCT05220059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Apple flavanols
Apple extract delivering 70 mg epicatechin
Delivered as a flavoured water based beverage
Apple extract delivering 140 mg epicatechin
Delivered as a flavoured water based beverage
Apple granules delivering 70 mg epicatechin
Delivered as a puree
Water delivering no epicatechin
Delivered as flavoured water
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Apple extract delivering 70 mg epicatechin
Delivered as a flavoured water based beverage
Apple extract delivering 140 mg epicatechin
Delivered as a flavoured water based beverage
Apple granules delivering 70 mg epicatechin
Delivered as a puree
Water delivering no epicatechin
Delivered as flavoured water
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Regular prescribed medication (excluding some eye and skin medication that is judged not to affect study outcome)
* Non-prescribed medication that may affect the study data, e.g. aspirin. The use of non prescribed medications will be assessed on an individual basis.
* Dietary supplements or herbal remedies which may affect the study data unless the volunteer is willing to discontinue them for 1 month prior to starting study. (Please note that some supplements may not affect the study and this will be assessed on an individual basis).
* Gastro-intestinal diseases (excluding hiatus hernia unless symptomatic or study intervention/procedure is contra-indicated).
* Diabetics
* Known cardiovascular disease
* Asthmatics (unless no medication taken for 1 year)
* Lactose Intolerance
* Pregnancy or have been pregnant within the last 12 months
* Parallel participation in another research project which involves dietary intervention
* Participation in another research project which has involved blood sampling within the last four months unless the total amount of combined blood from both studies does not exceed 470 mls.
* Has donated or intends to donate blood within 16 weeks prior to or during the study period.
* Depressed or elevated blood pressure measurements (\<90/50 or 95/55 if symptomatic or \>160/100)
* Any person related to or living with any member of the study team
* Results of the clinical screening which indicate or are judged by the HNU Medical Advisor to be indicative of a health problem which could compromise the well-being of the volunteer if they participated or which could affect the study data.
* Alcohol consumption \> approximately 20 g alcohol/day (2.5 units/day)
* BMI \<19.5 or \> 35
45 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danisco
INDUSTRY
Coressence LTD
UNKNOWN
Quadram Institute Bioscience
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Kroon
Role: PRINCIPAL_INVESTIGATOR
Quadram Institute Bioscience
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Food Research
Norwich, Norfolk, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Saha S, Hollands W, Needs PW, Ostertag LM, de Roos B, Duthie GG, Kroon PA. Human O-sulfated metabolites of (-)-epicatechin and methyl-(-)-epicatechin are poor substrates for commercial aryl-sulfatases: implications for studies concerned with quantifying epicatechin bioavailability. Pharmacol Res. 2012 Jun;65(6):592-602. doi: 10.1016/j.phrs.2012.02.005. Epub 2012 Feb 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IFR06-2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.